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The term ‘endotoxin tolerance’ defines a state in which prior
endotoxin (lipopolysaccharide (LPS)) exposure induces
resistance to subsequent LPS attack. However, its
characteristics within kidney have not been well defined.
Hence, this study tested the impact of LPS ‘preconditioning’
(LPS-PC; 18 or 72 h earlier) on: (i) selected renal inflammatory
mediators (tumor necrosis factor (TNF)-a, interleukin-10
(IL-10), monocyte chemotactic protein-1 (MCP-1), inducible
nitric oxide synthase (iNOS), Toll-like receptor 4 (TLR4); protein
or mRNA); (ii) cholesterol homeostasis (a stress reactant); and
(iii) isolated proximal tubule (PT) vulnerability to hypoxia or
membrane cholesterol (cholesterol oxidase/esterase) attack.
Two hours post LPS injection, LPS-PC mice manifested
reduced plasma TNF-a levels, consistent with systemic LPS
tolerance. However, in kidney, paradoxical TNF-a hyper-
reactivity (protein/mRNA) to LPS existed, despite normal TLR4
protein levels. PT TNF-a levels paralleled renal cortical results,
implying that PTs were involved. LPS-PC also induced: (i) renal
cortical iNOS, IL-10 (but not MCP-1) mRNA hyper-reactivity; (ii),
PT cholesterol loading, and (iii) cytoresistance to hypoxia and
plasma membrane cholesterol attack. A link between
cholesterol homeostasis and cell LPS responsiveness was
suggested by observations that cholesterol reductions in HK-2
cells (methylcyclodextrin), or reductions in HK-2 membrane
fluidity (A2C), blunted LPS-mediated TNF-a/MCP-1 mRNA
increases. In sum: (i) systemic LPS tolerance can be associated
with renal hyper-responsiveness of selected components
within the LPS signaling cascade (e.g., TNF-a, iNOS, IL-10);
(ii) PT cytoresistance against hypoxic/membrane injury
coexists; and (iii) LPS-induced renal/PT cholesterol accumulation
may mechanistically contribute to each of these results.
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In the aftermath of acute endotoxin exposure, animals
become relatively resistant to further endotoxin challenges.1–5
This state, denoted by the term ‘endotoxin tolerance’,
manifests itself by reductions in cytokine generation,
suppressed cell-mediated inflammation, and ultimately,
decreased tissue damage.1–5 The mechanism(s) by which
animals acquire endotoxin/lipopolysaccharide (LPS) tole-
rance remain poorly defined. However, downregulation of
Toll-like receptor(s) or of their ‘downstream’ signaling
pathways may be partially involved.1
Whether the kidney acquires LPS tolerance, and how such
tolerance might manifest itself, are unclear at this time.
Following LPS exposure, the kidney becomes relatively
resistant to nephrotoxin-induced acute renal failure (e.g.,
Honda et al.6 and Nath et al.7,8). Whether resistance to
ischemic injury also results is controversial.8,9 In states in
which LPS-induced renal cytoprotection against ischemia has
been observed,9 it has been mechanistically linked to a
downregulation of systemic inflammatory mediators, secon-
darily decreasing evolving renal damage.9,10 Whether LPS
tolerance directly protects proximal tubules (PTs) from
superimposed adenosine trisphosphate depletion injury has
not been defined. Furthermore, the impact of prior LPS
exposure on subsequent LPS-initiated inflammatory path-
ways remains unknown.
Given these considerations, this study was undertaken to
address the following specific aims: (1) determine whether
prior LPS exposure (‘LPS preconditioning’; LPS-PC) alters
subsequent LPS-mediated inflammatory/signaling events. Of
note in this regard is a recent report that experimental Gram-
negative sepsis, induced by cecal ligation and puncture,
upregulates PT Toll-like receptor 4 (TLR4) levels.11 This
result, as well as ‘endotoxin tolerance’, could each alter
subsequent renal sensitivity to LPS; (2) ascertain whether
LPS-PC directly induces proximal tubular cell resistance to
simulated ischemic (hypoxic) attack; (3) assess whether LPS
injection increases PT levels of cholesterol, a stress-induced
renal cytoprotectant;12 and (4) probe whether such choles-
terol alterations can potentially impact tubule cell resistance
to injury as well as LPS signaling events.
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RESULTS
Eighteen hours of LPS-PC: renal tumor necrosis factor-a
(protein) responses to subsequent LPS injection
As shown in Figure 1, mice that were subjected to 18 h of
LPS-PC had slight, but significant, baseline elevations in both
plasma and renal cortical tumor necrosis factor (TNF)-a
levels (vs controls without LPS exposure). Both groups of
mice responded to LPS with dramatic 2-h increases in plasma
and renal cortical TNF-a levels. However, the plasma TNF-a
increases were significantly blunted (B65%) in LPS-PC
mice, vs LPS-challenged naive controls (implying systemic
LPS tolerance). In contrast to plasma results, the LPS-PC
mice manifested significantly greater renal cortical TNF-a
increases upon LPS re-challenge, vs LPS-challenged naive
controls. Thus, these experiments indicated an apparent
dissociation of systemic (plasma) vs renal TNF-a responses to
LPS. The 18 h LPS-PC mice had elevated blood urea
nitrogens (6775 mg/dl) vs controls (2871 mg/dl; Po0.01).
However, plasma creatinines remained unchanged
(0.4070.02 mg/dl for each group).
Eighteen hours LPS-PC: effects on renal TNF-a, inducible
nitric oxide synthase, and interleukin-10 mRNA responses
to LPS
As shown in Figures 2 and 3 (left panel), 18 h LPS-PC mice
had slightly higher baseline renal cortical TNF-a mRNA,
inducible nitric oxide synthase (iNOS) mRNA, and inter-
leukin-10 (IL-10) mRNA values, vs controls. With a 2 h LPS
re-challenge, the preconditioned mice developed 26
greater renal cortical TNF-a mRNA (Figure 2), iNOS mRNA
(Figure 2), and IL-10 mRNA (Figure 3, left panel) increases
than did the LPS-challenged naive controls, indicating an LPS
hyper-responsive state.
Seventy-two hours LPS-PC: effects on TNF-a, iNOS, and IL-10
mRNA responses
The 72 h LPS-PC mice had slightly higher renal cortical TNF-
a mRNA, iNOS, and IL-10 mRNAs, vs controls (Figure 3,
right panel; Figure 4). The preconditioned mice retained
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Figure 1 | TNF-a (protein) levels in plasma (left panel) and in renal
cortex (right panel) in control mice, and in 18 h LPS-PC mice
either under basal conditions or 2 h after an LPS challenge. Left
panel: plasma TNF-a levels were basically undetectable in control
mice (o2 pg/ml), and they were slightly elevated in the 18 h LPS-PC
mice. At 2 h post LPS challenge, both the control and LPS-PC mice
manifested striking TNF-a plasma increases compared to their
baseline levels. However, the degree of increase was blunted by
approximately two-third in the LPS-PC mice vs the LPS challenged
controls. Hence, LPS-PC had induced a systemic ‘LPS tolerance’ state
(as gauged by plasma TNF-a increases). Right panel: baseline renal
cortical extract TNF-a levels were slightly elevated in the LPS-PC mice,
compared to naive controls. Both groups responded to LPS with an
acute increase in cortical TNF-a levels. However, unlike plasma levels,
the LPS-PC mice manifested a statistically greater renal cortical TNF-a
increase, compared to LPS-challenged naive controls. Thus, despite
systemic LPS tolerance in the LPS-PC mice (based on plasma TNF-a
levels), the LPS-PC mice manifested renal cortical hyper-
responsiveness to repeat LPS injection.
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Figure 2 | Renal cortical TNF-a mRNA (left panel) and iNOS mRNA
(right panel) values in control mice and 18 h LPS-PC mice either
under basal conditions or 2 h after an acute LPS challenge/
re-challenge. Left panel: at baseline, the 18 h LPS-PC mice had
slightly higher TNF-a mRNA values vs controls. Both groups of mice
responded to LPS injection with a dramatic increase in TNF-a mRNA;
however, the degree of increase was markedly exaggerated (B2 )
in the LPS-PC mice, indicating a renal cortical LPS hyper-responsive
state. Right panel: at baseline, LPS-PC mice had slightly higher iNOS
mRNA values than did controls. The control mice mounted only a
modest increase in iNOS mRNA by 2 h post LPS injection. Conversely,
a dramatic hyper-responsive state was observed in the LPS-PC mice,
with iNOS mRNA values increasingB6 more in the LPS-challenged
preconditioned mice, vs their LPS-challenged naive controls. Thus, as
with the TNF-a protein and TNF-a mRNA results, the iNOS mRNA
results also indicated that preconditioning had induced a renal
cortical hyper-responsive state.
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Figure 3 | Renal cortical IL-10 mRNA changes in control mice, 18 h
LPS-PC mice (left panel) and 72 h LPS-PC mice (right panel) under
basal conditions and 2 h after an acute LPS challenge/re-
challenge. Renal cortical IL-10 mRNA values were elevated in the
18 h LPS-PC mice (vs controls). When either the 18 or 72 h
preconditioned mice were re-challenged with LPS, far greater IL-10
mRNA increases resulted, vs those seen in LPS-challenged controls.
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hyper-responsiveness to LPS (2–6 greater increases in
TNF-a, iNOS, and IL-10 mRNAs, vs LPS-challenged controls;
assessed 2 h post LPS challenge).
The 72 h PS-PC mice had a two-third blunted increase in
plasma TNF-a levels in response to a 2 h LPS challenge,
compared to LPS-challenged controls (1103 vs 33927280 pg/ml;
Po0.015). This again implies systemic LPS tolerance at a
time of renal cortical hyper-responsiveness of TNF-a, iNOS,
and IL-10 mRNAs.
Renal cortical monocyte chemotactic protein-1 mRNA
responses
Baseline monocyte chemotactic protein-1 (MCP-1) mRNA
values were dramatically increased in both 18 and 72 h LPS-
PC mice (controls, 0.170.01; 18 h LPS-PC, 1.270.2; 72 h
LPS-PC, 1.470.3; Po0.01 vs controls). However, after the
2 h LPS challenge, no preferential MCP-1 mRNA increase was
observed in the LPS-PC vs the control group (2.270.4,
2.370.3, and 2.570.4; controls, 18 and 72 h LPS-PC,
respectively). No azotemia existed in the 72 h of LPS-PC
mice (blood urea nitrogen, 2873 mg/dl; creatinine,
0.470.02 mg/dl, nonsignificant vs controls).
Renal cortical TLR4 mRNA and protein: impact of LPS-PC
mRNA. Significant TLR4 mRNA increases were seen in both
the 18 h LPS-PC mice (Figure 5, left panel) and 72 h LPS-PC
mice (Figure 5, right panel), vs controls. Both sets of mice
manifested marked TLR4 mRNA increases by 2 h post LPS
challenge/re-challenge (Figure 5). Preconditioning did not
diminish the LPS-initiated TLR4 mRNA increases: if any-
thing, heightened sensitivity was suggested in the 18 h LPS-
PC animals.
Western blotting. As previously described and depicted,13
TLR4 appears as two closely related bands seen at B90 kDa.
LPS-PC did not increase TLR4 protein levels in renal cortex
(controls, 21987212 density units; 18 h LPS-PC, 17157154
density units) or in isolated tubules (controls, 2167776
density units; 18 h LPS-PC, 21417172 density units). When
assessed at 72 h post LPS injection, no difference in TLR4
protein levels was observed (controls, 20727216; LPS-PC,
20317145; nonsignificant). Thus, although the cecal ligation
and puncture sepsis model may increase TLR4 protein
levels,11 pure LPS injection need not produce this result.
LPS-PC: impact on proximal tubular resistance to hypoxic
injury
Eighteen hours LPS-PC. As shown in Figure 6, isolated PTs
harvested from control and 18 h post LPS-PC mice demon-
strated no significant difference in viability under control
(oxygenated) conditions. Exposure to either 7.5 min or
10 min of hypoxia, followed by reoxygenation, caused
stepwise increases in tubular cell death (% lactate dehydro-
genase (LDH) release) in control tubules. PTs obtained from
18 h LPS-PC mice manifested significant protection against
both the 7.5 and 10 min hypoxic challenge.
Seventy-two hours LPS PC. Tubules harvested from control
mice and 72 h LPS-PC mice were subjected to 10 min
hypoxic-reoxygenation injury. Again, tubules from LPS-PC
mice manifested partial resistance to lethal hypoxic damage
(Figure 6; Po0.015).
Assessment of TNF-a levels in isolated tubules
TNF-a levels were slightly elevated in isolated tubules
prepared from 18 h LPS-PC mice vs controls (Figure 7).
When tubules were harvested from control and LPS-PC mice
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Figure 4 | Renal cortical TNF-a and iNOS mRNA levels in control
mice and 72 h LPS-PC mice under basal conditions and 2 h
following an LPS challenge. The 72 h LPS-PC mice had slightly
elevated levels of TNF-a and iNOS mRNA at baseline, compared to
values seen in the controls. By 2 h post LPS injection, the 72 h LPS-PC
mice manifested hyper-responsiveness to LPS injection, as indicated
by 2 and 5 greater TNF-a and iNOS mRNA increases,
respectively, vs LPS-challenged naive controls. Thus, as with the 18 h
LPS-PC experimental results, 72 h LPS-PC mice also demonstrated
renal cortical hyper-responsiveness to LPS (as gauged by TNF-a and
iNOS mRNA increases).
PCC
LPS
PCC
(72 h)
PCC
LPS
PCC
(72 h)
0
0.5
1
1.5
2
2.5
3
3.5
TL
R
4/
G
AP
DH
 m
RN
A
3.5
3
2.5
2
1.5
1
0.5
0
<0.001
<0.01
<0.025
<0.005
<0.001
<0.05
Figure 5 | Renal cortical TLR4 mRNA levels in control mice, in 18 h
LPS-PC mice (left panel), and in 72 h LPS-PC mice (right panel)
under basal conditions and 2 h following an acute LPS challenge.
Left panel: after 18 h of LPS-PC, a significant increase in renal cortical
TLR4 mRNA was observed, compared to control tissues. Both the
control mice and the LPS-PC mice manifested brisk increases in TLR4
mRNA levels by 2 h post LPS injection. This acute response was
moderately, but not significantly, higher in the LPS-PC group. Right
panel: after 72 h of LPS-PC, slightly, but significantly, higher TLR4
mRNA values were seen in renal cortex, vs values seen in control
cortex. Both the control and 72 h LPS-PC mice developed marked
TLR4 mRNA increases by 2 h post LPS injection. That the LPS-PC mice
manifested as great of a response to LPS as did the control mice
indicated the absence of a renal cortical LPS-tolerant state.
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2 h post LPS challenge/re-challenge, a significantly greater
TNF-a increase was observed in the LPS-PC group. Thus,
these isolated tubule data confirm that the preferential renal
cortical TNF-a increases seen in LPS-PC mice upon LPS
re-challenge (Figure 1, data) reflected, at least in part, PT
(vs circulating cytokine/inflammatory cell) events.
LPS-PC: renal cholesterol levels and tubule resistance to
cholesterol attack
Cortical cholesterol assessments. Each of the employed LPS-
PC protocols caused significant increases in renal cortical
cholesterol/cholesterol ester content (Figure 8). At 72 h post
2 mg/kg LPS (not depicted), comparable cholesterol eleva-
tions were seen (LPS-PC, 285712 nmol/mmol; controls,
24872 nmol/mmol inorganic phosphate; Po0.015).
Isolated tubule cholesterol levels. Isolated tubules from
LPS-PC mice also had significantly higher cholesterol levels
than did control tubules (Figure 9), recapitulating the whole
renal cortex cholesterol results.
Resistance to cholesterol attack. As shown in Figure 10,
PTs harvested from LPS-PC mice showed significant
cytoresistance to direct plasma membrane cholesterol attack,
induced by either cholesterol esterase (CE) or cholesterol
oxidase (B35% reductions in lethal cell injury, LDH release,
vs identically challenged control tubules). Thus, as with the
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Figure 6 | Isolated PT susceptibility to hypoxic-reoxygenation (H/R)
injury. Isolated PTs, prepared from control mice, 18 h LPS-PC mice,
and 72 h LPS-PC mice were subjected to either control oxygenated
(O2) incubations  15 min or to either 7.5 or 10 min of hypoxia,
followed by 7.5 or 5 min reoxygenation, respectively. No significant
difference in tubule viability was observed between control tubules
or LPS-PC tubules under control (oxygenated) incubation conditions.
However, tubules obtained from LPS-PC mice manifested consistent
protection against H/R injury whether the challenge was 7.5 or
10 min of hypoxia, or whether the challenge was imposed at either 18
or 72 h of preconditioning. Cell injury was assessed by % LDH release.
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Figure 7 | TNF-a levels in isolated PTs obtained from control and
18 h LPS-PC mice without or with a 2 h LPS challenge. Baseline
TNF-a levels were slightly higher in tubules harvested from the 18 h
LPS-PC mice vs control mice. Both the preconditioned mice and
control mice manifested TNF-a increases in response to the 2 h LPS
challenge/re-challenge. The degree of increase was greater in the
LPS-PC mice than in the controls, confirming hyper-responsiveness to
LPS in the former group. Thus, these isolated tubule results were
consistent with the observations obtained in whole renal cortex.
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Figure 8 | Renal cortical free cholesterol (left panel) and
cholesterol ester (right panel) levels in control mice and mice
that had undergone 18 h of LPS-PC with either 2 or 10 mg/kg
LPS. Statistically significant increases in both free and esterified
cholesterol levels were observed in the LPS-PC groups, and in a
dose-dependent manner (*Pp0.02 vs control values).
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Figure 9 | Free cholesterol (left panel) and cholesterol ester (right
panel) levels in control (C) tubules and in tubules harvested from
18 h LPS-PC mice. Both free and esterified cholesterol levels were
significantly elevated in tubules from PC mice, indicating that the
elevations seen in renal cortex (Figure 8) reflected, at least in part,
proximal tubular cell events.
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above described hypoxia results, LPS-PC induced a direct PT
cytoresistant state, with membrane cholesterol resistance
likely being at least partially involved.
Impact of cell cholesterol on LPS-mediated signaling
Methylcyclodextrin/cholesterol extraction experiments. A 1-h
methylcyclodextrin (MCD) protocol was employed to reduce
HK-2 cell cholesterol by B30% (Zager et al.12), and then its
impact on LPS signaling was assessed. MCD did not
independently alter HK-2 TNF-a or MCP-1 mRNA levels
(Figure 11). LPS evoked massive TNF-a and MCP-1 mRNA
increases. MCD pre-treatment significantly blunted these
LPS-TNF-a/MCP-1 mRNA responses.
A2C membrane fluidity experiment. Increased membrane
cholesterol decreases membrane fluidity.12 Hence, the impact
of membrane fluidity on LPS signaling was also assessed.
Addition of a membrane fluidizing reagent (A2C; Zager
et al.12) to HK-2 cells did not independently alter TNF-a/
MCP-1 mRNA levels (Figure 12). However, A2C significantly
blunted LPS-mediated TNF-a and MCP-1 mRNA increments.
Thus, both cholesterol reduction (which increases membrane
fluidity) and a membrane-fluidizing reagent (A2C) induced
comparable reductions in LPS-driven TNF-a and MCP-1
mRNA responses.
DISCUSSION
Endotoxin tolerance is classically defined as a reduced
capacity of previously exposed animals to respond to a
second LPS challenge. However, this ‘hypo-responsiveness’ is
not necessarily global in its expression, given that selective
signaling pathways may be downregulated while leaving
others intact (e.g., Fan and Cook,1 Ziegler-Heitbrock,2
Cross,3 Learn et al.,4 Ziegler-Heitbrock et al.5). Characteriza-
tion of ‘LPS tolerance’ is further complicated by the fact that
tissue-specific differences in its expression may exist. Thus,
whereas LPS-preconditioned macrophages may downregulate
production of selected cytokines or chemokines, it cannot be
assumed that the same pattern will be observed in other cell
types or in whole tissues.1–5 Given these considerations, the
present study was undertaken to determine the impact of
LPS-PC on renal, and proximal tubular, responsiveness to
selected components within the LPS signaling cascade.
Toward this goal, a broad range of reactants, induced via
differing ‘downstream’ TLR4 pathways,14,15 were screened
(TNF-a, a pro-inflammatory cytokine; IL-10, an anti-
inflammatory cytokine; MCP-1, a chemokine; and iNOS,
producing the gaseous oxidant, NO).
That the employed LPS-PC protocols did, in fact, induce
systemic LPS tolerance was confirmed by the results of
plasma TNF-a assays. LPS injection into naive controls
evoked massive plasma TNF-a increases, rising from o2 to
B3000 pg/ml (determined at 2 h post LPS injection). This
response was reduced by approximately two-third in both the
18 and 72 h LPS-PC mice, with peak TNF-a levels of
B1100 pg/ml being observed. Paradoxically, the kidney failed
to participate in this LPS tolerant state: rather than mani-
festing suppressions in renal cortical TNF-a concentrations
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Figure 10 | Isolated tubule responses to direct plasma membrane
cholesterol attack with either cholesterol oxidase (CO) or CE.
With either a cholesterol oxidase or a CE challenge, tubules harvested
from 18 h LPS-PC mice demonstrated relative resistance to injury
(LDH release), compared to results observed in control tubules. Under
unchallenged conditions (far left two bars), no difference in viability
between control (C) and preconditioned mice (PC) was observed.
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Figure 11 | HK-2 cell TNF-a and MCP-1 mRNA responses to LPS
with and without acute cholesterol reductions. The cholesterol
stripping agent, MCD, did not impact levels of either mRNA under
basal conditions. However, MCD pretreatment significantly blunted
the degree of TNF-a and MCP-1 mRNA increases that resulted from a
3 h acute LPS exposure.
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Figure 12 | HK-2 cell TNF-a and MCP-1 mRNA responses to LPS
with and without the addition of a membrane-fluidizing agent,
A2C. A2C did not significantly alter basal TNF-a or MCP-1 mRNA
levels. However, A2C significantly blunted both mRNA responses to
LPS addition. Thus, both changes in membrane cholesterol (Figure
11, results) and cholesterol-associated changes in membrane fluidity
significantly impact LPS inflammatory signaling events.
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upon LPS re-challenge, the 2 h post LPS injection renal
cortical values were approximately twice as high in LPS-PC
mice, compared to LPS challenged naive controls. Renal
cortical TNF-a mRNA assessments underscored that the LPS-
PC mice did, in fact, paradoxically hyper-respond to LPS. As
shown in Figure 2, the TNF-a mRNA increases, assessed 2 h
post LPS re-challenge, were B2–3 times greater in the 18 h
LPS-PC mice, vs the naive, LPS challenged, controls. To
explore whether this hyper-responsiveness was simply a
transient phenomenon, TNF-a mRNA levels were also
assessed in 72 h LPS-PC mice. Once again, the LPS-PC mice
manifested two- to threefold greater renal cortical TNF-a
mRNA increases following LPS injection, compared to LPS
challenged controls. Notably, TNF-a assays performed on
isolated tubules obtained from LPS-PC and control mice
following an acute LPS challenge confirmed B2 higher
values in the former group. The significance of this finding is
that it confirms that the renal cortical results reflected, at least
in part, proximal tubular cell events (as opposed to
glomerular, vascular changes; infiltrating inflammatory cells,
or circulating cytokine levels). Finally, it is notable that this
renal cortical hyper-responsive state was not restricted to
TNF-a, given that LPS-mediated iNOS mRNA and IL-10
mRNA increases were Bthree- to sixfold greater in LPS-PC
mice, vs their equivalent controls. In contrast, LPS-mediated
MCP-1 mRNA increases were not enhanced in LPS-PC
animals. This simply underscores that although LPS-PC may
induce renal LPS ‘hyper-responsiveness’, this state need not
affect all components of the LPS-TLR4 inflammatory
cascade.
El-Achkar et al.11 recently reported increased PT TLR4
expression in the cecal ligation and puncture model of Gram-
negative sepsis. If purified LPS injection were to induce the
same result, it might explain the observed increase in renal
LPS responsiveness in preconditioned animals. However, the
available data seemingly rule out this possibility, given that
renal cortical/isolated tubule Western blots showed no TLR4
protein increases in 18 or 72 h LPS-PC animals. In contrast to
TLR4 protein, TLR4 mRNA levels were consistently increased
by LPS treatment. For example, B4 and 2 increases
were observed at 18 and 72 h post LPS injection, respectively.
Furthermore, at 2 h post LPS re-challenge, the precondi-
tioned kidneys mounted further sharp (B2 ) TLR4 mRNA
increases, equaling or exceeding those seen in LPS-challenged
controls. Indeed, the pronounced LPS-mediated TLR4
mRNA increases in preconditioned mice seem antithetical
to the presence of a renal ‘LPS tolerant state’, given that
decreased responsiveness would be expected. Of note, we
recently reported that renal TLR4 mRNA levels abruptly
increase in response to diverse forms of acute renal damage
(cisplatin, myohemoglobinuria, ischemia–reperfusion; Zager
et al.13). These latter findings help place the current
observation of LPS-induced TLR4 mRNA elevations in a
new perspective, that is, they may simply represent part of a
generic renal ‘stress response’, rather than reflecting an LPS-
specific change, per se.
As previously noted, there has been debate as to whether
LPS-PC protects against ischemia–reperfusion-induced acute
renal failure,8,9 and if so, whether that protection stems from
altered cytokine/chemokine profiles8 vs direct PT events. The
present isolated tubule experiments indicate that direct PT
cytoresistance against adenosine trisphosphate depletion
injury does, indeed, occur, based on observations that LPS-
PC tubules manifested resistance to hypoxic attack. To our
knowledge, this is the first demonstration that LPS-PC can
confer protection directly at the proximal tubular cell level
(vs being secondary to systemic inflammatory or hemody-
namic events). Indeed, this observation suggests a seeming
paradox: that renal tubular cytoresistance can be expressed,
or can coexist, with a renal LPS hyper-sensitivity state (as
denoted by the present TNF-a/iNOS/IL-10 data). It is notable
that we have documented this same pathophysiologic profile,
that is, increased renal LPS sensitivity in the setting of
acquired cytoresistance, in diverse structural models of acute
renal failure (e.g., rhabdomyolysis; cisplatin; ischemia–reper-
fusion; obstructive nephropathy; Zager et al.16–18). Thus, it
would appear that the present results, obtained with an
endotoxemic/hemodynamic model19–21 of renal injury, are
reflective of a much broader biologic principle than simply
‘endotoxin preconditioning’, that is, that diverse models of
acute renal stress can induce proximal tubular cytoresistance,
and that the latter can coexist with a potentially ‘injury-
amplifying’ (TNF-a/iNOS) hyper-inflammatory state.
Finally, it is tempting to speculate as to whether a
common pathway gives rise to, or contributes to, both post-
injury LPS hyper-responsiveness and the tubular cytoresis-
tance phenomenon. Although it is premature to draw firm
conclusions in this regard, renal cortical cholesterol accu-
mulation could be one such shared mechanism. We have
previously documented that in the aftermath of diverse forms
of nephrotoxic, ischemic, and obstructive renal injury, renal
cortical/PT cholesterol levels rise, and that the cholesterol
increases help confer cellular resistance to subsequent
hypoxic and toxic attack.12,22–31 This mechanistic association
has been deduced from the following observations: prevent-
ing cholesterol accumulation (with statins), normalizing
cholesterol in post-injured cytoresistant tubules (with MCD),
or altering cholesterol integrity, each predisposes to tubular
injury and/or reverses the cytoresistant state.12,22–31 We now
confirm that endotoxemia, like other renal insults, also
increases proximal tubular cholesterol content. That direct
plasma membrane resistance to cholesterol attack results
(decreased LDH release in response to CE or oxidase) further
supports this mechanistic link. It is noteworthy that plasma
membrane cholesterol may alter non-LPS-driven cell signal-
ing events.32–35 Therefore, we have tested, for the first time,
whether changes in tubular cell cholesterol levels can alter
LPS responsiveness. Preliminary studies indicate that the
answer is yes. Using an MCD protocol that reduces HK-2 cell
cholesterol by B30%,12 an approximate 30% reduction in
LPS-mediated TNF-a and MCP-1 mRNA generation re-
sulted. Plasma membrane cholesterol accumulation decreases
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membrane fluidity.12 Hence, we assessed whether membrane
fluidity might also impact HK-2 cell LPS responsiveness.
Again the answer was yes: the membrane-fluidizing reagent
A2C blunted the LPS-mediated TNFa/MCP-1 mRNA
increases, again by B30%. As A2C and MCD have each
been shown to decrease cytoresistance,12 it seems plausible
that injury-induced cholesterol increases, with decreased
membrane fluidity, could contribute both to cytoresistance as
well as the post-injury LPS hyper-responsive state. Indeed,
cholesterol loading could help to explain why LPS-PC, as
induced in this study, failed to initiate a classic renal
‘endotoxin tolerant’ state. Further exploration of this
intriguing ‘unifying cholesterol hypothesis’ is required, and
this remains an active area of investigation within this
laboratory.
MATERIALS AND METHODS
Animal utilization
All in vivo experiments were conducted with male CD-1 mice
(25–30 g), obtained from Charles River Laboratories (Wilmington,
MA, USA). They were maintained under routine vivarium conditions
with free food and water access. Tail vein (intravenous) injections
were performed with 26 G needles after placing the mice in restraining
tubes. Kidneys resections were performed through midline abdominal
incisions under pentobarbital (40–50 mg/kg) anesthesia. Kidneys were
immediately iced, the cortices were dissected, and subjected to either
protein or total RNA extraction.27 Terminal heparinized blood
samples were drawn from the inferior vena cava.
In vivo experiments
LPS-PC: effect on renal TNF-a, iNOS, IL-10, MCP-1, and TLR4
expression. Eighteen hours of LPS-PC: Mice were injected with
Escherichia coli LPS (10 mg/kg; 0111:B4; L-2630; Sigma Chemicals
(St Louis, MO, USA); in B80 ml saline; n, 12) or its saline vehicle
(control group; n, 12). Eighteen hours later, the mice received a
second tail vein injection of either LPS (2 mg/kg) or vehicle, creating
the following four groups (n, 6 per group):
Group (1): control mice (saline injection at baseline, and
again 18 h later);
Group (2): LPS-PC mice (baseline LPS; followed by saline
injection 18 h later);
Group (3): control mice/LPS challenge (saline at baseline,
followed by LPS 18 h later);
Group (4): LPS-PC mice/LPS challenge (baseline LPS;
followed by LPS 18 h later).
Two hours following the second intravenous injection, plasma
and kidney samples were obtained, as noted above. The plasma
samples were analyzed for blood urea nitrogen, creatinine, and TNF-
a concentrations (by enzyme-linked immunosorbent assay; R&D
Systems, Minneapolis, MN, USA; Zager et al.16). Tissues from one
kidney underwent protein extraction and were analyzed for TNF-a
(by enzyme-linked immunosorbent assay; Zager et al.16). The
contralateral cortical tissue samples underwent RNA extraction.
Analyses for TNF-a, iNOS, MCP-1, IL-10, and TLR4 mRNAs were
performed by competitive reverse transcriptase-polymerase chain
reactions as described previously.13,16–18 Simultaneously obtained
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) product
served as a housekeeping gene (individual results being expressed
as a ratio to the simultaneously obtained GAPDH product).
Seventy-two hour of LPS-PC: The above experiment was repeated
with the following exceptions: (i) a 72 h period was allowed
following initial LPS injection; and (ii) the preconditioning LPS
dosage was 2 mg/kg (as not all mice could survive for 72 h following
10 mg/kg LPS injection).
TLR4 Western blot analyses. Renal cortical protein extracts,
obtained from the following groups of mice, underwent TLR4
Western blot analysis:13 six control kidneys; six kidneys obtained
18 h post 10 mg/kg LPS injection; six kidneys obtained 72 h post
2 mg/kg LPS injection; and six time matched (72 h) controls. To gain
PT-specific results, TLR4 was probed in isolated PTs obtained from
18 h LPS-PC mice (n, 4) and control mice (n, 4), as described below.
The results were expressed as densitometry units.13
Isolated PT experiments
Tubular susceptibility to hypoxic injury: impact of LPS-PC.
Eighteen hours of LPS-PC: Mice were injected with either LPS
(10 mg/kg intravenous) or saline vehicle (n, 4 each). Eighteen hours
later, they were anesthetized with pentobarbital, a blood sample was
obtained for blood urea nitrogen/creatinine determination, and then
the kidneys were resected and iced. Cortical PTs were isolated by
collagenase digestion/differential centrifugation,12 and placed in
experimentation buffer.12 One control and one LPS-exposed mouse
were studied in pairs on any given day. The PT preparations from
each mouse were each divided into four equal aliquots, maintained
at 371C in 10 ml Erlenmeyer flasks, and subjected to one of the
following conditions: (1) control (oxygenated) incubation (95% O2/
5% CO2) 15 min; (2) 7.5 min of hypoxia (95% N2/5% CO2),
followed by 7.5 min of reoxygenation; (3) 10 min of hypoxiaþ 5 min
reoxygenation; and (4) a second control incubation. Lethal cell injury
was assessed by % LDH release.12
Seventy-two hours of LPS-PC: Four mice were injected with 2 mg/
kg of LPS or vehicle. PTs were harvested 72 h later, and subjected to
10 min of hypoxiaþ 5 min reoxygenation, or 15 min control
(oxygenated) incubation. LDH release was then assessed.
Assessments of tubule TNF-a cytokine and TLR4 protein
levels. PTs were prepared from the following groups of mice
(n, 4 per group): (1) control tubules; (2) LPS-PC mice (injected 18 h
earlier with 10 mg/kg); (3) non-conditioned mice 2 h post LPS
injection (2 mg/kg); and (4) LPS-PC mice 2 h after re-challenging
with LPS. The tubules were kept at isolation temperature (41C),
protein extracts were prepared, and assayed for TNF-a. To gauge PT
TLR4 content, control and LPS-PC tubule protein extracts were
probed for TLR4 by Western blot, as above.13
Cholesterol experiments
Renal cortical/PT cholesterol assessments. Five groups (n, 4
each) of mice were created as follows: (Groups 1 and 2): 2 or 10 mg/
kg LPS exposure 18 h; (Group 3): 2 mg/kg LPS exposure 72 h;
(Groups 4 and 5): 18 or 72 h time matched controls. At the
appropriate times, the kidneys were removed, the cortices were
dissected, subjected to lipid extraction, and assayed for free and
esterified cholesterol by gas chromatography.23 Values were
expressed as nmol/mmol phospholipid phosphate (Pi).23 To confirm
that the whole cortex results reflected, at least in part, PT events,
cholesterol/cholesterol ester levels were also assessed in isolated
tubules obtained from five control mice and five mice precondi-
tioned 18 h earlier with 10 mg/kg LPS.
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Proximal tubular resistance to direct cholesterol attack. To
ascertain whether tubular cholesterol loading alters cellular resis-
tance to direct cholesterol attack, five sets of isolated tubules,
obtained from five normal mice and five 18 h LPS-PC mice, were
prepared and divided into four aliquots: (1) control incubation; (2)
exposure to cholesterol oxidase (2 U/ml; Zager22); exposure to CE
(1 U/ml; Zager22); or (4) second control incubation. After 30 min, %
LDH release was assessed.
HK-2 cell cholesterol content as a potential modifier of LPS
responsiveness. HK-2 proximal tubular cells were cultured in 16
T25 flasks.12 Four groups (four flasks per group) were created: (1)
control incubation; (2) B30% cholesterol reduction, induced with
MCD (a cholesterol ‘stripper’; 10 mM1 h followed by washout;
Zager et al.12); (3) LPS challenge (10 mg/ml 3 h); (4) LPS
challenge 3 h in MCD pretreated cells (note: all cells underwent
the same washing procedures as used to remove MCD). At the end
of the 4 h experiment, TNF-a, MCP-1, and GAPDH mRNAs were
assessed.16,17
Membrane fluidity as a potential modifier of LPS responsive-
ness. Because increases in cholesterol reduce plasma membrane
fluidity,12 the impact of membrane fluidity on TNF-a/MCP-1
mRNA responsiveness to LPS was assessed. Four experimental
groups (n, 4 each) of HK-2 cells in T25 flasks were established: (1)
control incubation 4 h; (2) incubation 4 h with 100 mM A2C
(Zager et al.,12 a fluidizing reagent); (3) 1 h control incubationþ 3 h
LPS exposure (10 mg/ml); and (4) A2C 1 h followed by 3 h of
combined A2Cþ LPS exposure. At the end of the 4 h experiments,
TNF-a, MCP-1, and GAPDH mRNA levels were assessed.
Calculations and statistics
All values are expressed as means71 s.e.m. Statistical comparisons
were performed by paired or unpaired Student’s t-test. mRNA
results were expressed as a ratio to simultaneously determined
GAPDH product.
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